Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open-label, multi-center, single arm, Proof of Concept, 16-week, Liver Fat Imaging Study of LPCN-1144 to Assess Liver Fat Changes in Hypogonadal Men at Risk of Developing Non-Alcoholic Steatohepatitis (NASH) using MRI-PDFF Technique

Next Previous
Trial Profile

An open-label, multi-center, single arm, Proof of Concept, 16-week, Liver Fat Imaging Study of LPCN-1144 to Assess Liver Fat Changes in Hypogonadal Men at Risk of Developing Non-Alcoholic Steatohepatitis (NASH) using MRI-PDFF Technique

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs LPCN-1144 (Primary)
  • Indications Non-alcoholic steatohepatitis
  • Focus Adverse reactions; Proof of concept; Therapeutic Use

    • Most Recent Events

    • 26 Mar 2019 According to a Lipocine media release, abstract for late-breaker presentation on LPCN 1144 clinical results from this study has been accepted as part of The International Liver Congress 2019, the annual meeting of the European Association for the Study of the Liver (EASL; April 10th-14th in Vienna, Austria)
    • 18 Mar 2019 Results presented at the 101st Annual Meeting of the Endocrine Society
    • 12 Mar 2019 Status changed from active, no longer recruiting to completed, as reported in a Lipocine Media Release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top